Zydus Lifesciences launches ANVIMO
ANVIMO will be available in dosages of 240 mg and 480 mg
ANVIMO will be available in dosages of 240 mg and 480 mg
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Subscribe To Our Newsletter & Stay Updated